Understanding HNF1B Gene Disruption

A recent study identified a novel chromosomal inversion causing **HNF1B gene disruption**. This discovery occurred in a patient with renal cysts and diabetes (RCAD) syndrome. This rare condition involves multisystem issues, specifically affecting the kidneys and the pancreas. Consequently, identifying this de novo variant highlights the complex genetic architecture of pediatric polycystic kidney disease. Researchers utilized whole-genome sequencing to pinpoint this previously unreported structural variant at the 17q12 locus.

Clinical Features of RCAD Syndrome

Patients with this syndrome typically exhibit bilateral renal cysts. Clinicians often detect these anomalies during the fetal period. Furthermore, many individuals develop maturity-onset diabetes of the young (MODY5) as they age. Other manifestations can include genital tract malformations and elevated liver enzymes. However, the severity of symptoms varies significantly among patients. Therefore, accurate diagnosis often requires advanced molecular tools rather than clinical observation alone.

The Clinical Value of Whole-Genome Sequencing

Whole-genome sequencing (WGS) proved essential in identifying this **HNF1B gene disruption**. Standard exome sequencing often misses complex structural variants like chromosomal inversions. Specifically, the study identified the inversion (GRCh38:17:g.36934029_37729559inv) which physically breaks the HNF1B gene sequence. Consequently, this disrupts the protein\'s ability to regulate organ development. This case underscores the diagnostic power of WGS in cases of unexplained or progressively worsening pediatric renal disease.

Genetic Counseling and Patient Management

Genetic counseling provides vital support for families dealing with HNF1B-related disorders. Since many variants occur de novo, an absence of family history does not rule out the condition. Moreover, managing RCAD requires a multidisciplinary approach involving nephrologists and endocrinologists. Early detection allows for the proactive monitoring of kidney function and blood glucose. Ultimately, personalized care plans based on genetic findings may improve long-term patient outcomes.

FAQ

What is RCAD syndrome?

Renal Cysts and Diabetes (RCAD) syndrome is a genetic condition caused by mutations or structural changes in the HNF1B gene. It manifests as kidney cysts and early-onset diabetes.

How does HNF1B gene disruption affect health?

This disruption prevents the gene from producing the transcription factors necessary for proper kidney and pancreas development. This results in structural anomalies and metabolic dysfunction.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.

References

Wang Y et al. A novel inversion at 17q12 disrupting HNF1B gene in a patient with renal cysts and diabetes syndrome. BMC Med Genomics. 2026 Feb 17. doi: 10.1186/s12920-026-02325-6. PMID: 41703530.

HNF1B-related autosomal dominant tubulointerstitial kidney disease - Orphanet. Available from: https://www.orpha.net/

Renal cysts and diabetes syndrome — Knowledge Hub - Genomics Education Programme. Available from: https://www.genomicseducation.hee.nhs.uk/